Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering
BackgroundThe advent of biologics has significantly transformed treatment strategies for neuromyelitis optica spectrum disorder (NMOSD). However, there are no biomarkers that predict relapses associated with steroid tapering; therefore, it is critical to identify potential indicators of disease acti...
Saved in:
| Main Authors: | Ryohei Yamamura, Makoto Kinoshita, Yoshiaki Yasumizu, Tomohiro Yata, Keigo Kihara, Daisuke Motooka, Naoyuki Shiraishi, Yasuko Sugiyama, Shohei Beppu, Hisashi Murata, Naoshi Koizumi, Itsuki Sano, Toru Koda, Tatsusada Okuno, Hideki Mochizuki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1508977/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Very-late-onset neuromyelitis optica spectrum disorder: a case report and review
by: Rui-Ting Liu, et al.
Published: (2025-04-01) -
Prediction of apolipoprotein A-I and high-density lipoprotein cholesterol in the neurological impairment and relapse of neuromyelitis optica spectrum disorder
by: Yanyan Wang, et al.
Published: (2025-07-01) -
Prevalence of epsilon toxin-producing Clostridium perfringens isolates among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Iran
by: Masoumeh Azimirad, et al.
Published: (2025-05-01) -
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)
by: Julian Reza Kretschmer, et al.
Published: (2025-04-01) -
Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
by: Mariano Marrodan, et al.
Published: (2025-08-01)